Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12907595.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
INK4a-ARF and p53 inactivation are common but rarely concurrent findings in glioblastoma multiforme. Here we demonstrate that experimental deletion of either tumor suppressor gene cooperates with retrovirally expressed platelet-derived growth factor (PDGF)-B regarding both tumor latency and frequency in a mouse brain tumor model. We find indications of PTEN down-regulation and increased Akt phosphorylation in both types of null tumors (although more prominent in p53-/- tumors) suggesting a possible mechanism for this synergism. This is the first time that the cooperative tumorigenic effects of PDGF-B stimulation and p53 loss of function are demonstrated in an in vivo model, establishing a functional link between two common molecular changes of human secondary glioblastoma multiforme.
Medical subject headings
- Brain Neoplasms
- Cyclin-Dependent Kinase Inhibitor p16
- Genes, p53
- Glioblastoma
- Platelet-Derived Growth Factor
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins c-sis
- Tumor Suppressor Protein p14ARF